Skip to content

The deal

Type
IPO
Amount
$317.5M
Status
Closed
Valuation
Not recorded
Region
United States
Date
22 October 2026

As of this development: a later development may record new terms.

Lifecycle

  1. FiledNot recorded
  2. Closed22 October 2026 · This development

The parties

Lycia Therapeutics Inc. Issuer

1 development · 1 deal in Minutes